We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Valiant Mona LSA Stent Graft System

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01839695
First Posted: April 25, 2013
Last Update Posted: March 13, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Medtronic Endovascular
Results First Submitted: October 24, 2014  
Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: None (Open Label);   Primary Purpose: Treatment
Condition: Thoracic Aortic Aneurysms
Intervention: Device: Valiant Mona LSA Stent Graft System

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Valiant Mona LSA Stent Graft System

TEVAR procedure using Medtronic Stent Graft >

> Valiant Mona LSA Stent Graft System: All subjects will be implanted with this device


Participant Flow:   Overall Study
    Valiant Mona LSA Stent Graft System
STARTED   9 
COMPLETED   9 
NOT COMPLETED   0 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Valiant Mona LSA Stent Graft System

TEVAR procedure using Medtronic Stent Graft >

> Valiant Mona LSA Stent Graft System: All subjects will be implanted with this device


Baseline Measures
   Valiant Mona LSA Stent Graft System 
Overall Participants Analyzed 
[Units: Participants]
 9 
Age 
[Units: Years]
Mean (Standard Deviation)
 72.89  (7.61) 
Sex: Female, Male 
[Units: Participants]
Count of Participants
 
Female      6  66.7% 
Male      3  33.3% 
Race (NIH/OMB) 
[Units: Participants]
Count of Participants
 
American Indian or Alaska Native      0   0.0% 
Asian      0   0.0% 
Native Hawaiian or Other Pacific Islander      0   0.0% 
Black or African American      2  22.2% 
White      5  55.6% 
More than one race      0   0.0% 
Unknown or Not Reported      2  22.2% 
Region of Enrollment 
[Units: Participants]
 
United States   7 
United Kingdom   2 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Primary Safety Observation - Rate of Major Adverse Events (MAEs)   [ Time Frame: 1 month ]

2.  Primary:   Primary Effectiveness Observation   [ Time Frame: 1 month ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: Anna Busman, Sr. Clinical Research Specialist
Organization: Medtronic Vascular
phone: 707-591-7633
e-mail: rs.medtroniccardiovascularclinicaltrials@medtronic.com


Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Medtronic Endovascular
ClinicalTrials.gov Identifier: NCT01839695     History of Changes
Other Study ID Numbers: 10086370DOCRev1C
First Submitted: April 11, 2013
First Posted: April 25, 2013
Results First Submitted: October 24, 2014
Results First Posted: October 29, 2014
Last Update Posted: March 13, 2017